Product NDC: | 24987-362 |
Proprietary Name: | ZANTAC |
Non Proprietary Name: | ranitidine hydrochloride |
Active Ingredient(s): | 25 mg/mL & nbsp; ranitidine hydrochloride |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 24987-362 |
Labeler Name: | Covis Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019090 |
Marketing Category: | NDA |
Start Marketing Date: | 20130315 |
Package NDC: | 24987-362-10 |
Package Description: | 10 VIAL in 1 CARTON (24987-362-10) > 2 mL in 1 VIAL |
NDC Code | 24987-362-10 |
Proprietary Name | ZANTAC |
Package Description | 10 VIAL in 1 CARTON (24987-362-10) > 2 mL in 1 VIAL |
Product NDC | 24987-362 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ranitidine hydrochloride |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20130315 |
Marketing Category Name | NDA |
Labeler Name | Covis Pharmaceuticals, Inc. |
Substance Name | RANITIDINE HYDROCHLORIDE |
Strength Number | 25 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |